nktr-255
Showing 1 - 4 of 4
Lung Cancer Trial in Houston (NKTR-255, Durvalumab)
Not yet recruiting
- Lung Cancer
- NKTR-255
- Durvalumab
-
Houston, TexasM D Anderson Cancer Center
Nov 30, 2022
Multiple Myeloma, Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma Trial in United States (NKTR-255, NKTR-255 Q21, Rituximab)
Recruiting
- Multiple Myeloma
- +2 more
- NKTR-255
- +3 more
-
Goodyear, Arizona
- +16 more
Mar 18, 2022
Head and Neck Squamous Cell Carcinoma, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma Trial in United States (NKTR-255,
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +4 more
- NKTR-255
- Cetuximab
-
Scottsdale, Arizona
- +11 more
Mar 31, 2022
Locally Advanced or Metastatic Urothelial Carcinoma Trial in United States (Avelumab, Sacituzumab Govitecan, M6223)
Recruiting
- Locally Advanced or Metastatic Urothelial Carcinoma
- Avelumab
- +3 more
-
Coeur d'Alene, Idaho
- +19 more
Oct 4, 2022